He began his talk discussing the biggest and most known robotic company – Intuitive Inc. This company continues to dominate the market of surgical robots since FDA approval of the da Vinci® Surgical System in 2000. DaVinci has continued to innovate over the years with 5 different models – standard, S, Si, Xi, and the most recent single port (SP) system, with improved instrumentation and optics. However, there are many new companies trying to join the market. These include:
- Senhance (TransEnterix surgical Inc)
- Revo-i® robotic surgical system (South Korea)
- Versius® Robot (CMR Surgical)
- Avatera robot (The German robot)
- SPORT (TITAN medical)
- VERB surgical robot (Google + Johnson and Johnson)
The REVO-I robotic surgical system from South Korea (Figure 1), has a closed console, with haptic feedback, 20 use limit of the instruments, and is very similar to the DaVinci system. It does have larger ports (12.2 mm camera port, 9.3 mm instrument ports), and is already available in the South Korean market. There have also been several studies demonstrating the successful usage of this robot in performing Retzius sparing robotic radical prostatectomy, with encouraging perioperative, early oncological and continence outcomes. (1,2)
The VERSIUS robot is an open console (the surgeon can either sit or stand) and uses small instruments (5.8 mm). It has separate arm resulting in a lower chance of clashing, portable and easy to move, more freedom in port positions and robot docking, and can be fitted in most small OR theatres. Lastly, the ports are not attached to the robotic arms. (Figure 2).
The Avatera (the German robot) is also similar to the DaVinci robot system. It has four arms, with a smaller console that provides 3D vision (Figure 3).
Figure 1 – The REVO-I South Korean Robot:
Figure 2 – The VERSIUS Robot:
Figure 3 – The Avatera Tobot:
The SPORT (TITAN medical) robot is a single port orifice technology robot and is hypothesized to be a competitor to the Da Vinci SP robot (Figure 4). It also has an open console dependent on 3D eyeglasses, and multi-articulated instruments. It already has generated some data, showing favorable preliminary clinical experience.
Figure 4 – The SPORT Robot:
The last robot discussed was the VERB surgical robot, that does not have much data available publicly. It is featured to have a virtual reality headset and perhaps a 360-degree camera. It is scheduled to be released to the market in 2020.
Presented by: Ketan Badani, MD, Icahn School of Medicine, Mount Sinai
Written By: Hanan Goldberg, MD, Urologic Oncology Fellow (SUO), University of Toronto, Princess Margaret Cancer Centre @GoldbergHanan at 2019 3rd Annual North American Robotic Urology Symposium (NARUS), February 8-9, 2018 - Las Vegas, Nevada, United States
References:
1. Chang KD et al. Retzius-sparing robot-assisted radical prostatectomy using the Revo-i robotic surgical system: surgical technique and results of the first human trial. BJU Int. 2018 Sep:122(3):441-448.
2. Kim DK et al. Eur Urol 2018
1. Chang KD et al. Retzius-sparing robot-assisted radical prostatectomy using the Revo-i robotic surgical system: surgical technique and results of the first human trial. BJU Int. 2018 Sep:122(3):441-448.
2. Kim DK et al. Eur Urol 2018